Publications by authors named "Dustin Little"

Claim this Profile
C
Changing paradigms of studies in kidney diseases.
Adeera Levin, Allison Jaure, Dustin J Little, Jane Schell, Jennifer S Lees

Kidney Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin.
Robin Myte, Andrea Mattsson, Matt Poole, Dustin J Little, Per Nyström

Circ Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Strategic Roadmap to Support Communication on and Acceptance of Surrogate Endpoints: The REnal Surrogacy accEpTance in Chronic Kidney Disease (RESET CKD) Collaboration.
Juan José Garcia Sanchez, Marta Trapero-Bertran, Oriana Ciani, Bruno Detournay, Loreto Gesualdo, Dustin J Little

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The authors reply.
Dustin J Little, Samvel B Gasparyan, Patrick Schloemer

Kidney Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.
Jamie P Dwyer, Noha Maklad, Ola Vedin, John Monyak, Robin Myte, Dustin J Little

J Am Soc Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of the glomerular filtration rate slope to the kidney hierarchical composite endpoint.
Dustin J Little, Niels Jongs, Meike Brinker, Samvel B Gasparyan, Patrick Schloemer

Kidney Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of eGFR Slope Thresholds as End Point Components in a Kidney Disease Progression Hierarchical Composite End Point.
Niels Jongs, Samvel B Gasparyan, Lars Frison, Patrick Schloemer, Meike Brinker, Dustin J Little

J Am Soc Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.
Laura H Mariani, Howard Trachtman, Aliza Thompson, Barbara S Gillespie, Michelle Denburg, Dustin J Little

Am J Kidney Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial designs to assess treatment effects on glomerular filtration rate decline.
Hiddo J L Heerspink, Dustin J Little, Lars Frison, Samvel B Gasparyan, Christoph Wanner

Kidney Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Conceptual Model of Physical Functioning Limitations Experienced by Patients with Late-Stage Chronic Kidney Disease: A Qualitative Interview Study.
Ewelina Palmer, Ichha Johar, Dustin J Little, Niklas Karlsson

Adv Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semiquantitative Paper-Based Microfluidic Surrogate Virus Neutralization Test for SARS-CoV-2 Neutralizing Antibodies.
Md Almostasim Mahmud, Liangcheng Henry Xu, Anat Usatinsky, Claudia C Dos Santos, Dustin J Little

Anal Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review.
Dustin J Little, Samvel B Gasparyan, Patrick Schloemer, Niels Jongs, Meike Brinker

J Am Soc Nephrol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression.
Hiddo J L Heerspink, Niels Jongs, Patrick Schloemer, Dustin J Little, Meike Brinker

J Am Soc Nephrol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-Care Ultrasound Use in Nephrology: A Survey of Nephrology Program Directors, Fellows, and Fellowship Graduates.
David L Cook, Samir Patel, Robert Nee, Dustin J Little, Scott D Cohen

Kidney Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for Popov et al., "Distinct Molecular Features of NleG Type 3 Secreted Effectors Allow for Different Roles during Citrobacter rodentium Infection in Mice".
Georgy Popov, Aline Fiebig-Comyn, Lukas Syriste, Dustin J Little, Tatiana Skarina

Infect Immun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data.
Dustin J Little, Matthew Arnold, Katarina Hedman, Ping Sun, Syed Asif Haque

BMC Nephrol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999-2018 National Health and Nutrition Examination Survey.
Csaba P Kovesdy, Jill R Davis, Ian Duling, Dustin J Little

Clin Kidney J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Molecular Features of NleG Type 3 Secreted Effectors Allow for Different Roles during Citrobacter rodentium Infection in Mice.
Georgy Popov, Aline Fiebig-Comyn, Lukas Syriste, Dustin J Little, Tatiana Skarina

Infect Immun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
Kieran F Docherty, Paul Welsh, Subodh Verma, Rudolf A De Boer, Eileen O'Meara, Dustin J Little

Circulation· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.
Pablo E Pergola, Chaim Charytan, Dustin J Little, Stefan Tham, Lynda Szczech

Kidney360· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TPR domain of PgaA is a multifunctional scaffold that binds PNAG and modulates PgaB-dependent polymer processing.
Roland Pfoh, Adithya S Subramanian, Jingjing Huang, Dustin J Little, Adam Forman

PLoS Pathog· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
Steven Fishbane, Carol A Pollock, Mohamed El-Shahawy, Elizabeth T Escudero, Anjay Rastogi, Dustin J Little

J Am Soc Nephrol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." . 2021;6:613-623.
Robert Provenzano, Steven Fishbane, Lynda Szczech, Robert Leong, Khalil G Saikali, Dustin J Little

Kidney Int Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Uncommon Clinical Events in USA Patients with Dialysis-Dependent and Nondialysis-Dependent Chronic Kidney Disease: Analysis of Electronic Health Records from TriNetX.
Alyshah Abdul Sultan, Glen James, Xia Wang, Seth Kuranz, Katarina Hedman, Dustin Little

Nephron· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.
Robert Provenzano, Lynda Szczech, Robert Leong, Khalil G Saikali, Ming Zhong, Dustin J Little

Clin J Am Soc Nephrol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis